Who makes Tavapadon [14C] suspension?

Tavapadon [14C] suspension is developed by Cerevel Therapeutics, LLC.

What development phase is Tavapadon [14C] suspension in?

Tavapadon [14C] suspension is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Tavapadon [14C] suspension

Cerevel Therapeutics, LLC · Phase 1 active Small molecule

At a glance

Generic name	Tavapadon [14C] suspension
Sponsor	Cerevel Therapeutics, LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tavapadon [14C] suspension CI brief — competitive landscape report
Tavapadon [14C] suspension updates RSS · CI watch RSS
Cerevel Therapeutics, LLC portfolio CI